Hyper-targeting CAR NK cells from induced pluripotent stem cells for novel off-the-shelf anti-tumor therapies

Project: Research

Project Details

AcronymHyperTargIPS-NK
StatusActive
Effective start/end date2023/04/01 → 2026/03/31

Collaborative partners

  • Lund University
  • Amniotics AB (lead)
  • Hannover Medical School
  • University of Copenhagen

Funding

  • European Commission - Horizon Europe